|
Volumn 174, Issue 2-3, 2008, Pages 111-119
|
The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations
|
Author keywords
Performance testing; Regulatory requirements; Specimen validity testing; Workplace drug testing
|
Indexed keywords
3,4 METHYLENEDIOXYAMPHETAMINE;
3,4 METHYLENEDIOXYMETHAMPHETAMINE;
AMPHETAMINE DERIVATIVE;
CANNABIS;
COCAINE;
DIAMORPHINE;
N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE;
OPIATE;
PHENCYCLIDINE;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CUSTODY;
DRUG SCREENING;
DRUG USE;
FLUID INTAKE;
GOVERNMENT;
HAIR ANALYSIS;
HEALTH PROGRAM;
HEALTH SERVICE;
HUMAN;
INFORMATION PROCESSING;
LABORATORY TEST;
MEDICAL PERSONNEL;
MENTAL HEALTH SERVICE;
PATCH TEST;
PERFORMANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SUBSTANCE ABUSE;
SWEAT TEST;
URINALYSIS;
WORKPLACE;
|
EID: 37649022048
PISSN: 03790738
EISSN: None
Source Type: Journal
DOI: 10.1016/j.forsciint.2007.03.008 Document Type: Article |
Times cited : (162)
|
References (13)
|